Clinical Trial Update: Rhythmic Estradiol and Bone Health [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating rhythmic estradiol for bone health in women at risk of osteoporosis and during menopause. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Menopause
• Osteoporosis

Drugs mentioned

• ESTRADIOL (Estradiol)

Snippet

Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | Conditions: Osteoporosis Risk, Menopause | Phase 4 | Status: COMPLETED